Tag: Multiple Sclerosis
Lower Levels of Depression, Higher QOL for Older MS Patients
Individuals aged 55 to 65 years have less severe depressive symptoms, better physical QOL
Brain Iron on MRI Linked to Disability in Multiple Sclerosis
Lower thalamic susceptibility, higher susceptibility of the globus pallidus linked to clinical disability
Fingolimod Cuts Multiple Sclerosis Relapses in Pediatric Patients
Compared with interferon beta-1a, less lesion accumulation seen on MRI but more adverse events
Ibudilast Appears to Slow Brain Atrophy Progression in MS
In phase 2 randomized trial, 2.5 ml less brain-tissue loss with ibudilast than with placebo over 96 weeks
Organic Solvents + Genetics May Increase Risk of Multiple Sclerosis
Finding of susceptibility seen regardless of smoking status
Dynamics of Brain Volume Loss Vary With MS Progression
Limited reproducibility of estimates seen using different imaging methods
Various Clinical Disturbances Precede MS Diagnosis
Understanding prodromal signs may improve multiple sclerosis identification
FDA Expands Use of MS Drug to Include Children
Gilenya is the first multiple sclerosis drug approved for children
Guidelines Developed for Use of Drugs in Multiple Sclerosis
Guidelines relate to starting, switching, stopping disease-modifying therapies
Siponimod Cuts Risk of Disability Progression in Multiple Sclerosis
Reduction in 3-month confirmed disability progression in secondary progressive multiple sclerosis
